Doctor Krister Jarbrink
BioPharmaceuticals Medical, AstraZeneca, Gothenburg (Sweden)
Cardiac manifestations as precursors to ATTR amyloidosis diagnosis: results from the multi-country OverTTuRe study
Event: Heart Failure 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment
REVEAL-CKD: Prevalence of undiagnosed stage 3 chronic kidney disease in patients with heart failure in Canada
Event: Heart Failure 2023
Topic: Comorbidities
Session: Chronic heart failure - comorbidities
